Table 1 Signalments, comorbidities, medications, and clinical history of the dogs in each cough grade group
Characteristic | Grade 0 (n = 15) | Grade 1 (n = 18) | Grade 2 (n = 18) |
|---|---|---|---|
Age (years) (median, range) | 12 (7–17) | 12 (4–16) | 11.5 (6–15) |
Sex, n (%) | Â | Â | Â |
Male | 0 (0%) | 1 (5.6%) | 0 (0%) |
Male castrated | 8 (53.3%) | 8 (44.4%) | 12 (66.7%) |
Female | 1 (6.7%) | 0 (0%) | 2 (11.1%) |
Female spayed | 6 (40%) | 9 (50%) | 4 (22.2%) |
Breed (n) | Toy and Miniature Poodle (5) | Pomeranian (6) | Pomeranian (6) |
| Â | Pomeranian (3) | Maltese (5) | Maltese (5) |
| Â | Maltese (3) | Toy and Miniature Poodle (2) | Chihuahua (4) |
| Â | Mixed (2) | Mixed (2) | Toy and Miniature Poodle (1) |
| Â | Shihtzu (1) | Shihtzu (1) | Shihtzu (1) |
| Â | Spitz (1) | Silky terrier (1) | Yorkshire terrier (1) |
| Â | Â | Beagle (1) | Â |
Comorbidity, n (%) | Â | Â | Â |
No comorbidity | 0 (0%) | 1 (5.6%) | 1 (5.6%) |
MMVD | 10 (66.7%) | 14 (77.8%) | 12 (66.7%) |
B1 | 5 (33.3%) | 1 (5.6%) | 1 (5.6%) |
B2 | 3 (20%) | 6 (33.3%) | 4 (22.2%) |
C | 2 (13.3%) | 7 (38.9%) | 7 (38.9%) |
Medication, n (%) | Â | Â | Â |
None | 10 (66.7%) | 7 (38.9%) | 3 (16.7%) |
Theophylline | 5 (33.3%) | 11 (61.1%) | 15 (83.3%) |
Codeine | 0 (0%) | 4 (22.2%) | 10 (55.6%) |
≥ 3 drugs | 0 (0%) | 2 (11.1%) | 5 (27.8%) |
Clinical history, n (%) | Â | Â | Â |
< 3 months | 5 (33.3%) | 5 (27.8%) | 8 (44.4%) |
3–6 months | 1 (6.7%) | 1 (5.6%) | 0 (0%) |
> 6 months | 9 (60%) | 12 (66.7%) | 10 (55.6%) |